{"log_id": 8129595584594415039, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0, "average": 0.998792, "min": 0.998792}, "location": {"width": 27, "top": 65, "height": 82, "left": 1094}, "words": "品"}, {"probability": {"variance": 5e-06, "average": 0.998462, "min": 0.992103}, "location": {"width": 266, "top": 203, "height": 34, "left": 169}, "words": "华法令和其他香豆素类衍生物"}, {"probability": {"variance": 1.3e-05, "average": 0.997433, "min": 0.985916}, "location": {"width": 790, "top": 228, "height": 47, "left": 168}, "words": "健康志愿者服用氟伐他汀和华法令(单剂),与单独服用华法令相比,对华法令的血浆浓"}, {"probability": {"variance": 1.3e-05, "average": 0.997787, "min": 0.98068}, "location": {"width": 789, "top": 268, "height": 46, "left": 169}, "words": "度或凝血酶原时间无不良影响。但是,有同时服用本品和华法令或其他香豆素类衍生物的"}, {"probability": {"variance": 0.001067, "average": 0.990584, "min": 0.802984}, "location": {"width": 795, "top": 307, "height": 48, "left": 169}, "words": "患者发生出血和或凝血酶原时间延长的个例报告。因此,在使用华法令和其他香豆素类衍"}, {"probability": {"variance": 3.4e-05, "average": 0.997196, "min": 0.968252}, "location": {"width": 769, "top": 346, "height": 47, "left": 169}, "words": "生物的患者中,在氟伐他汀开始,结束和调整剂量的时候,建议密切监测凝血酶原时间"}, {"probability": {"variance": 2e-05, "average": 0.997888, "min": 0.987852}, "location": {"width": 126, "top": 441, "height": 26, "left": 172}, "words": "口服降糖药物"}, {"probability": {"variance": 0.005677, "average": 0.982426, "min": 0.524689}, "location": {"width": 794, "top": 460, "height": 49, "left": 168}, "words": "在使用磺脲类药物(格列苯脲,甲苯磺丁脲)治疗的2型糖尿病患者中使用氟伐他汀,没"}, {"probability": {"variance": 3e-06, "average": 0.998687, "min": 0.993538}, "location": {"width": 249, "top": 512, "height": 34, "left": 170}, "words": "有发现具有临床意义的变化"}, {"probability": {"variance": 0.004577, "average": 0.985599, "min": 0.558325}, "location": {"width": 770, "top": 540, "height": 45, "left": 169}, "words": "对于采用格列苯脲进行治疗的2型糖尿病患者(n=32),同时服用氟伐他汀(每次40mg"}, {"probability": {"variance": 0.002111, "average": 0.98556, "min": 0.709506}, "location": {"width": 768, "top": 577, "height": 45, "left": 173}, "words": "每天2次,连续14天)可以使格列苯脲的Cmx、AUC以及半衰期分别增加50%、69和"}, {"probability": {"variance": 0.001965, "average": 0.984168, "min": 0.763314}, "location": {"width": 754, "top": 615, "height": 47, "left": 175}, "words": "21%。格列苯脲(每次5至20mg)可以使氟伐他汀的Cmax和AUC分别增加44%和"}, {"probability": {"variance": 0.000171, "average": 0.990076, "min": 0.971591}, "location": {"width": 38, "top": 676, "height": 21, "left": 177}, "words": "51%"}, {"probability": {"variance": 0.000238, "average": 0.994677, "min": 0.910101}, "location": {"width": 797, "top": 691, "height": 47, "left": 175}, "words": "在这个试验中,血糖,胰岛素和C肽水平没有变化。但是,对于同时使用格列苯脲和氟伐"}, {"probability": {"variance": 2.2e-05, "average": 0.997159, "min": 0.973798}, "location": {"width": 679, "top": 732, "height": 45, "left": 177}, "words": "他汀的患者,如果氟伐他汀剂量增加至每天80mg,应对患者进行适当的监测"}, {"probability": {"variance": 0, "average": 0.998815, "min": 0.998315}, "location": {"width": 114, "top": 821, "height": 25, "left": 182}, "words": "【药物过量】"}, {"probability": {"variance": 2.4e-05, "average": 0.997344, "min": 0.978878}, "location": {"width": 802, "top": 837, "height": 51, "left": 177}, "words": "在一项40例高胆固醇血症患者参加的安慰剂对照的研究中,服用氟伐他汀钠缓释片剂量高"}, {"probability": {"variance": 1.4e-05, "average": 0.997726, "min": 0.981221}, "location": {"width": 612, "top": 882, "height": 44, "left": 176}, "words": "达320mg/日(每个剂量组n=7),超过2周,均显示出良好的耐受性"}, {"probability": {"variance": 3.1e-05, "average": 0.997846, "min": 0.967502}, "location": {"width": 671, "top": 919, "height": 44, "left": 176}, "words": "如果药物过量服用,无特殊的方法和建议。必要时可以采取对症和支持治疗"}, {"probability": {"variance": 1.6e-05, "average": 0.997134, "min": 0.989301}, "location": {"width": 115, "top": 1006, "height": 29, "left": 186}, "words": "【临床试验】"}, {"probability": {"variance": 0.00013, "average": 0.994858, "min": 0.960831}, "location": {"width": 209, "top": 1043, "height": 32, "left": 179}, "words": "中国注册临床试验数据"}, {"probability": {"variance": 0.000132, "average": 0.99457, "min": 0.941695}, "location": {"width": 787, "top": 1064, "height": 49, "left": 180}, "words": "在一项多中心、双盲、活性药物对照,319例原发性高胆固醇血症和混合型血脂异常中国"}, {"probability": {"variance": 0.000133, "average": 0.995114, "min": 0.934037}, "location": {"width": 725, "top": 1105, "height": 47, "left": 180}, "words": "受试者参加的中国注册临床试验中,比较了每日一次服用氟伐他汀钠缓释片80mg"}, {"probability": {"variance": 8e-06, "average": 0.997404, "min": 0.986733}, "location": {"width": 655, "top": 1145, "height": 44, "left": 201}, "words": "n=159)和每日一次服用氟伐他汀钠胶囊40mg(n=160)治疗12周的疗效"}, {"probability": {"variance": 4.8e-05, "average": 0.996937, "min": 0.958896}, "location": {"width": 804, "top": 1179, "height": 50, "left": 181}, "words": "氟伐他汀钠缓释片80mg降低中国受试者的LDLC,总胆固醇和甘油三酯比氟伐他汀钠胶囊"}, {"probability": {"variance": 1.9e-05, "average": 0.997753, "min": 0.980011}, "location": {"width": 772, "top": 1217, "height": 50, "left": 187}, "words": "4mg更为有效(参见表2)。原发性高胆固醇血症和混合型血脂异常受试者的结果一致"}, {"probability": {"variance": 0.000186, "average": 0.993416, "min": 0.94276}, "location": {"width": 803, "top": 1255, "height": 50, "left": 183}, "words": "中国受试者的LDLC降低程度与国外本品关于原发性高胆固醇血症和混合型血脂异常的注"}, {"probability": {"variance": 0.006926, "average": 0.971972, "min": 0.563709}, "location": {"width": 770, "top": 1296, "height": 48, "left": 183}, "words": "册试验结果相同。与氟伐他汀钠胶囊40mg组1.25%(2160)相比,氟伐他汀钠缓释片"}, {"probability": {"variance": 0.005382, "average": 0.968796, "min": 0.635057}, "location": {"width": 782, "top": 1336, "height": 51, "left": 181}, "words": "8mg组6.92%(1159),有更多的患者出现肝功能转氨酶检测(>3xULN单次检测)"}, {"probability": {"variance": 0, "average": 0.999829, "min": 0.999802}, "location": {"width": 45, "top": 1394, "height": 24, "left": 184}, "words": "异常"}, {"probability": {"variance": 0.005889, "average": 0.952436, "min": 0.8196}, "location": {"width": 128, "top": 1358, "height": 54, "left": 717}, "words": "州分公司"}, {"probability": {"variance": 0.000399, "average": 0.994842, "min": 0.895198}, "location": {"width": 519, "top": 1451, "height": 42, "left": 183}, "words": "表2:12周后与基线水平相比的平均变化百分率所有患者"}], "language": 3}